Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Lung Cancer Clinical Trials in Chicago | 559 Studies

Clinical Trials Lung CancerChicago

Lung Cancer Clinical Trials in Chicago

Find 559 clinical trials for lung cancer near Chicago, Illinois. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 559 trials

CompletedStudy of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based TreatmentThe purpose of this clinical study is to determine the effectiveness (ability to provide beneficial treatment of the disease) and safety of pralatrexate compared to erlotinib when…NCT00606502·Bakersfield, California and 46 others

Lung Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

WithdrawnTesting the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung CancerThis phase II Lung-MAP treatment trial tests whether carboplatin and pemetrexed with or without selpercatinib works to shrink tumors in patients with RET fusion-positive non-small…NCT05364645·Jonesboro, Arkansas and 264 others

TerminatedS0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone SurgeryRATIONALE: A program that includes bupropion may be more effective in helping early-stage lung cancer patients to quit smoking.NCT00032084·Anniston, Alabama and 175 others

TerminatedBasket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsThis is an open-label, multicenter, multinational, Phase 2 basket study exploring the efficacy and safety of neratinib as monotherapy or in combination with other therapies in…NCT01953926·Birmingham, Alabama and 59 others

TerminatedGSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerThe purpose of this clinical trial is to demonstrate the benefit of the immunotherapeutic product GSK1572932A when given to patients with Non-Small Cell Lung Cancer, after removal…NCT00480025·Birmingham, Alabama and 619 others

TerminatedPilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With PembrolizumabThis trial will evaluate safety and tolerability of letetresgene autoleucel (GSK3377794) with or without pembrolizumab in participants with non-small cell lung cancer.NCT03709706·Duarte, California and 30 others

CompletedM7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC)The purpose of the study is to evaluate the efficacy and safety of bintrafusp alfa (M7824) compared with pembrolizumab in participants with advanced NSCLC with high PD-L1-tumor…NCT03631706·Huntsville, Alabama and 118 others

CompletedCarboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During SurgeryRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003387·Birmingham, Alabama and 46 others

RecruitingA Study of LY4050784 in Participants With Advanced or Metastatic Solid TumorsThe main purpose of this study is to find out whether the study drug, LY4050784, is safe, tolerable and effective in participants alone or in combination with other anticancer…NCT06561685·Santa Monica, California and 32 others

CompletedBLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryRATIONALE: Vaccines may help the body build an effective immune response to kill tumor cells. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways.NCT00828009·Palo Alto, California and 87 others

RecruitingA Study of Sigvotatug Vedotin in Advanced Solid TumorsThis trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have…NCT04389632·Anchorage, Alaska and 157 others

RecruitingA Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerThis study will assess the effect of Dato-DXd in combination with osimertinib or Dato-DXd monotherapy versus platinum-based doublet chemotherapy in terms of progression-free…NCT06417814·Fayetteville, Arkansas and 302 others

RecruitingEsomeprazole and Radiation Induced EsophagitisThoracic radiation therapy combined with chemotherapy (with or without immunotherapy) is the cornerstone of management in patients with locally advanced non-small cell lung cancer…NCT06120803·Chicago, Illinois

CompletedA Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid TumorsAn open-label, dose-escalation (Part 1), dose-expansion (Part 2) study to assess the safety, pharmacokinetics (PK), and preliminary efficacy of ABBV-155 alone and in combination…NCT03595059·Birmingham, Alabama and 39 others

Active not recruitingErlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung CancerThis randomized phase II trial studies how well giving erlotinib hydrochloride and cabozantinib-s-malate alone or in combination works as second or third line therapy in treating…NCT01708954·Scottsdale, Arizona and 355 others

CompletedCombination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung CancerThis phase II clinical trial studies how well combining different regimens of chemotherapy and gefitinib with radiation therapy work in treating patients with stage III non-small…NCT00040794·Chicago, Illinois

Active not recruitingStudy With Various Immunotherapy Treatments in Participants With Lung CancerThe purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tolerability of…NCT05676931·Birmingham, Alabama and 52 others

Active not recruitingTesting the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung CancerThis phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer…NCT06732401·Jonesboro, Arkansas and 191 others

CompletedRadiation Therapy in Treating Patients With Stage I Non-Small Cell Lung CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells.NCT00960999·Auburn, California and 37 others

CompletedSafety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung CarcinomaThis randomized phase II clinical trial evaluates the combination of a monoclonal antibody-based drug (SGN-15) with a chemotherapeutic agent compared to chemotherapy given alone…NCT00051571·Los Angeles, California and 8 others

PreviousPage 7 of 28Next

Other Conditions in Chicago

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma